Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

González-de-Olano D, Matito A, Orfao A, Escribano L.

F1000Res. 2016 Nov 14;5:2666. Review.

2.

Survey on practice of venom immunotherapy in France.

Dzviga C, Matevi C, Bonniaud P, Lavaud F, Girodet B, Birnbaum J, Lambert C; Interest Group on Insect Venom Hypersensitivity Allergy from the French Society of Allergology (SFA).; French Federation of Continuous Medical Education in Allergology (ANAFORCAL)..

Arch Med Sci. 2016 Feb 1;12(1):150-5. doi: 10.5114/aoms.2016.57591.

3.

Risk associated with bee venom therapy: a systematic review and meta-analysis.

Park JH, Yim BK, Lee JH, Lee S, Kim TH.

PLoS One. 2015 May 21;10(5):e0126971. doi: 10.1371/journal.pone.0126971. Review.

4.

Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders.

Valent P.

Clin Exp Allergy. 2014 Jul;44(7):914-20. doi: 10.1111/cea.12318. Review.

5.

Mastocytosis: update on pharmacotherapy and future directions.

Cardet JC, Akin C, Lee MJ.

Expert Opin Pharmacother. 2013 Oct;14(15):2033-45. doi: 10.1517/14656566.2013.824424. Review.

6.

Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom.

Stoevesandt J, Hofmann B, Hain J, Kerstan A, Trautmann A.

Allergy Asthma Clin Immunol. 2013 Sep 2;9(1):33. doi: 10.1186/1710-1492-9-33.

7.

Management of insect sting hypersensitivity: an update.

Pesek RD, Lockey RF.

Allergy Asthma Immunol Res. 2013 May;5(3):129-37. doi: 10.4168/aair.2013.5.3.129.

8.

Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Castells M, Metcalfe DD, Escribano L.

Am J Clin Dermatol. 2011 Aug 1;12(4):259-70. doi: 10.2165/11588890-000000000-00000. Review.

9.

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.

Molderings GJ, Brettner S, Homann J, Afrin LB.

J Hematol Oncol. 2011 Mar 22;4:10. doi: 10.1186/1756-8722-4-10. Review.

10.

Clinical immunology review series: an approach to desensitization.

Krishna MT, Huissoon AP.

Clin Exp Immunol. 2011 Feb;163(2):131-46. doi: 10.1111/j.1365-2249.2010.04296.x. Review.

11.

Mast cell activation syndrome: Proposed diagnostic criteria.

Akin C, Valent P, Metcalfe DD.

J Allergy Clin Immunol. 2010 Dec;126(6):1099-104.e4. doi: 10.1016/j.jaci.2010.08.035.

12.

Mastocytosis.

Brockow K, Metcalfe DD.

Chem Immunol Allergy. 2010;95:110-24. doi: 10.1159/000315946. Review.

13.

Assessing anaphylactic risk? Consider mast cell clonality.

Metcalfe DD, Schwartz LB.

J Allergy Clin Immunol. 2009 Mar;123(3):687-8. doi: 10.1016/j.jaci.2009.02.003. No abstract available.

Items per page

Supplemental Content

Support Center